NXTC logo

NextCure (NXTC) Cash From Operations

Annual CFO

-$52.97 M
+$912.00 K+1.69%

December 31, 2023


Summary


Performance

NXTC Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNXTCcash flowmetrics:

Quarterly CFO

-$11.45 M
-$1.68 M-17.16%

September 30, 2024


Summary


Performance

NXTC Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNXTCcash flowmetrics:

TTM CFO

-$44.51 M
+$1.32 M+2.89%

September 30, 2024


Summary


Performance

NXTC TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNXTCcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NXTC Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.7%0.0%0.0%
3 y3 years-17.8%+9.5%+11.1%
5 y5 years-762.8%-44.1%-24.9%

NXTC Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.5%-28.0%+25.9%at high+24.3%
5 y5-year-48.7%+7.5%-82.5%+33.5%-24.9%+24.3%
alltimeall time-762.8%+7.5%-151.0%+33.5%-656.9%+24.3%

NextCure Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$11.45 M(+17.2%)
-$44.51 M(-2.9%)
Jun 2024
-
-$9.78 M(-22.4%)
-$45.83 M(-9.8%)
Mar 2024
-
-$12.61 M(+18.1%)
-$50.80 M(-4.1%)
Dec 2023
-$52.97 M(-1.7%)
-$10.67 M(-16.5%)
-$52.97 M(+3.4%)
Sep 2023
-
-$12.78 M(-13.4%)
-$51.25 M(-4.2%)
Jun 2023
-
-$14.75 M(-0.2%)
-$53.48 M(+0.5%)
Mar 2023
-
-$14.78 M(+65.1%)
-$53.22 M(-1.2%)
Dec 2022
-$53.89 M(-5.9%)
-$8.95 M(-40.3%)
-$53.89 M(-7.8%)
Sep 2022
-
-$15.00 M(+3.5%)
-$58.42 M(+4.2%)
Jun 2022
-
-$14.49 M(-6.2%)
-$56.09 M(-4.6%)
Mar 2022
-
-$15.45 M(+14.5%)
-$58.82 M(+2.7%)
Dec 2021
-$57.28 M
-$13.49 M(+6.5%)
-$57.28 M(+14.4%)
Sep 2021
-
-$12.66 M(-26.5%)
-$50.07 M(-5.7%)
Jun 2021
-
-$17.22 M(+23.8%)
-$53.08 M(+10.0%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$13.91 M(+121.6%)
-$48.27 M(+7.4%)
Dec 2020
-$44.95 M(+26.2%)
-$6.28 M(-59.9%)
-$44.95 M(-7.6%)
Sep 2020
-
-$15.67 M(+26.3%)
-$48.67 M(+18.9%)
Jun 2020
-
-$12.41 M(+17.1%)
-$40.94 M(+4.6%)
Mar 2020
-
-$10.59 M(+6.0%)
-$39.14 M(+9.9%)
Dec 2019
-$35.62 M(-545.7%)
-$9.99 M(+25.7%)
-$35.62 M(+1027.0%)
Sep 2019
-
-$7.95 M(-25.1%)
-$3.16 M(-4817.9%)
Jun 2019
-
-$10.61 M(+49.8%)
$67.00 K(-98.8%)
Mar 2019
-
-$7.08 M(-131.5%)
$5.71 M(-28.5%)
Dec 2018
$7.99 M(-163.9%)
$22.47 M(-576.2%)
$7.99 M(-155.2%)
Sep 2018
-
-$4.72 M(-4.8%)
-$14.48 M(+48.4%)
Jun 2018
-
-$4.96 M(+3.2%)
-$9.76 M(+103.2%)
Mar 2018
-
-$4.80 M
-$4.80 M
Dec 2017
-$12.51 M
-
-

FAQ

  • What is NextCure annual cash flow from operations?
  • What is the all time high annual CFO for NextCure?
  • What is NextCure annual CFO year-on-year change?
  • What is NextCure quarterly cash flow from operations?
  • What is the all time high quarterly CFO for NextCure?
  • What is NextCure quarterly CFO year-on-year change?
  • What is NextCure TTM cash flow from operations?
  • What is the all time high TTM CFO for NextCure?
  • What is NextCure TTM CFO year-on-year change?

What is NextCure annual cash flow from operations?

The current annual CFO of NXTC is -$52.97 M

What is the all time high annual CFO for NextCure?

NextCure all-time high annual cash flow from operations is $7.99 M

What is NextCure annual CFO year-on-year change?

Over the past year, NXTC annual cash flow from operations has changed by +$912.00 K (+1.69%)

What is NextCure quarterly cash flow from operations?

The current quarterly CFO of NXTC is -$11.45 M

What is the all time high quarterly CFO for NextCure?

NextCure all-time high quarterly cash flow from operations is $22.47 M

What is NextCure quarterly CFO year-on-year change?

Over the past year, NXTC quarterly cash flow from operations has changed by $0.00 (0.00%)

What is NextCure TTM cash flow from operations?

The current TTM CFO of NXTC is -$44.51 M

What is the all time high TTM CFO for NextCure?

NextCure all-time high TTM cash flow from operations is $7.99 M

What is NextCure TTM CFO year-on-year change?

Over the past year, NXTC TTM cash flow from operations has changed by $0.00 (0.00%)